Basis: Trailing twelve months (TTM). Source: stored company filings and market data; unavailable inputs remain N/A.
The enterprise value (EV) is $-9.86M.
ENTERPRISE VALUE (EV)
$-9.86M
Decoy Therapeutics Inc.
Market Cap
$853809.00
Enterprise Value (EV)
$-9.86M
| NAME | MARKET CAP | ENTERPRISE VALUE (EV) |
|---|---|---|
| Decoy Therapeutics Inc. (DCOY) | $853809.00 | $-9.86M |
| Bone Biologics Corporation (BBLG)vs › | $851060.00 | N/A |
| GlucoTrack, Inc. (GCTK)vs › | $873967.00 | N/A |
| Bluejay Diagnostics, Inc. (BJDX)vs › | $834083.00 | N/A |
| Aspire Biopharma Holdings, Inc. (ASBP)vs › | $1.02M | N/A |
| CDT Equity Inc. (CDT)vs › | $668876.00 | $971.24M |
| Clearmind Medicine Inc. (CMND)vs › | $1.07M | N/A |
| Cellyan Biotechnology Co., Ltd (HKPD)vs › | $1.11M | $2.14M |
| IM Cannabis Corp. (IMCC)vs › | $1.16M | $9.69M |
| HCW Biologics Inc. (HCWB)vs › | $549273.00 | $6.37M |
Market Cap
$853809.00
Total Debt
$0.00
Cash
$10.71M
Enterprise Value
$-9.86M
Why use EV instead of Market Cap?
Enterprise Value represents the total value of a company as if you were to acquire it completely - paying for equity while assuming debt and receiving cash.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
